TY - JOUR
T1 - Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images
T2 - a study from the Lunenburg lymphoma biomarker consortium
AU - Natkunam, Yasodha
AU - de Jong, Daphne
AU - Farinha, Pedro
AU - Gaulard, Philippe
AU - Klapper, Wolfram
AU - Rosenwald, Andreas
AU - Sander, Birgitta
AU - Tooze, Reuben
AU - Advani, Ranjana
AU - Burton, Catherine
AU - Gribben, John G.
AU - Kersten, Marie-José
AU - Kimby, Eva
AU - Lenz, Georg
AU - Molina, Thierry
AU - Morschhauser, Franck
AU - Scott, David
AU - Sehn, Laurie
AU - Stevens, Wendy
AU - Clear, Andrew
AU - Baia, Maryse
AU - Habi, Abdelmalek
AU - Elsensohn, Mad-Helenie
AU - Langlois-Jacques, Carole
AU - Maucort-Boulch, Delphine
AU - Calaminici, Maria
N1 - Publisher Copyright: © 2023 The Authors. Histopathology published by John Wiley & Sons Ltd.
PY - 2023/6
Y1 - 2023/6
N2 - Aims: Subclassification of large B cell lymphoma (LBCL) is challenging due to the overlap in histopathological, immunophenotypical and genetic data. In particular, the criteria to separate diffuse large B cell lymphoma (DLBCL) and high-grade B cell lymphoma (HGBL) are difficult to apply in practice. The Lunenburg Lymphoma Biomarker Consortium previously reported a cohort of over 5000 LBCL that included fluorescence in-situ hybridisation (FISH) data. This cohort contained 209 cases with MYC rearrangement that were available for a validation study by a panel of eight expert haematopathologists of how various histopathological features are used. Methods and results: Digital whole slide images of haematoxylin and eosin-stained sections allowed the pathologists to visually score cases independently as well as participate in virtual joint review conferences. Standardised consensus guidelines were formulated for scoring histopathological features and included overall architecture/growth pattern, presence or absence of a starry-sky pattern, cell size, nuclear pleomorphism, nucleolar prominence and a range of cytological characteristics. Despite the use of consensus guidelines, the results show a high degree of discordance among the eight expert pathologists. Approximately 50% of the cases lacked a majority score, and this discordance spanned all six histopathological features. Moreover, none of the histological variables aided in prediction of MYC single versus double/triple-hit or immunoglobulin-partner FISH-based designations or clinical outcome measures. Conclusions: Our findings indicate that there are no specific conventional morphological parameters that help to subclassify MYC-rearranged LBCL or select cases for FISH analysis, and that incorporation of FISH data is essential for accurate classification and prognostication.
AB - Aims: Subclassification of large B cell lymphoma (LBCL) is challenging due to the overlap in histopathological, immunophenotypical and genetic data. In particular, the criteria to separate diffuse large B cell lymphoma (DLBCL) and high-grade B cell lymphoma (HGBL) are difficult to apply in practice. The Lunenburg Lymphoma Biomarker Consortium previously reported a cohort of over 5000 LBCL that included fluorescence in-situ hybridisation (FISH) data. This cohort contained 209 cases with MYC rearrangement that were available for a validation study by a panel of eight expert haematopathologists of how various histopathological features are used. Methods and results: Digital whole slide images of haematoxylin and eosin-stained sections allowed the pathologists to visually score cases independently as well as participate in virtual joint review conferences. Standardised consensus guidelines were formulated for scoring histopathological features and included overall architecture/growth pattern, presence or absence of a starry-sky pattern, cell size, nuclear pleomorphism, nucleolar prominence and a range of cytological characteristics. Despite the use of consensus guidelines, the results show a high degree of discordance among the eight expert pathologists. Approximately 50% of the cases lacked a majority score, and this discordance spanned all six histopathological features. Moreover, none of the histological variables aided in prediction of MYC single versus double/triple-hit or immunoglobulin-partner FISH-based designations or clinical outcome measures. Conclusions: Our findings indicate that there are no specific conventional morphological parameters that help to subclassify MYC-rearranged LBCL or select cases for FISH analysis, and that incorporation of FISH data is essential for accurate classification and prognostication.
KW - FISH
KW - MYC-rearrangement
KW - diffuse large B cell lymphoma
KW - digital whole slide image
KW - high-grade B cell lymphoma
UR - http://www.scopus.com/inward/record.url?scp=85150932636&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150932636&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36849712
U2 - https://doi.org/10.1111/his.14896
DO - https://doi.org/10.1111/his.14896
M3 - Article
C2 - 36849712
SN - 0309-0167
VL - 82
SP - 1105
EP - 1111
JO - Histopathology
JF - Histopathology
IS - 7
ER -